Explained | India’s diabetes epidemic is making India’s TB epidemic worse
The HinduLong before COVID-19 devastated us, India has been experiencing the double burden of two debilitating and severe epidemics – type 2 diabetes and tuberculosis. DM also increases the likelihood of unfavourable TB treatment outcomes, such as treatment failure, relapse/reinfection, and even death. Persistent inflammation has also been seen in people with DM and TB – even after they have completed their TB treatment, speaking to the combined impact of these diseases even after a ‘cure’. Experts have reported that TB-related respiratory complications have been a common cause of death among people with TB and DM, but which wasn’t the case with people with TB only. An important part of this is to improve the nutritional status of people with TB as well as DM, as this can help increase the chances of favourable TB-treatment outcomes.